A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO EVALUATE THE EFFICACY,SAFETY AND TOLERABILITY OF PSILOCYBIN ORAL SOLUTION IN TREATING DEPRESSION AMONG ADULTS WITH (PTSD) Sponsor name: APEX LABS INC.
Date of no objection letter: 2023–01–04
Trial status: PENDING ~ A 2-PART, PHASE 2A, RANDOMIZED, DOUBLE-BLIND TRIAL TO EVALUATE THE SAFETY, TOLERABILITY, AND…